Royce Porter Occupational Therapist Medicare: Medicare Enrolled Practice Location: 250 W 300 N, Roosevelt, UT 84066 Phone: 435-725-7448 |
Greg Neilsen, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 250 W 300 N, Roosevelt, UT 84066 Phone: 435-722-6186 |
Ryan James Avery, MOTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 250 W 300 N, Roosevelt, UT 84066 Phone: 435-722-4691 |
Amanda Garner, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 136 South 500 East, Roosevelt, UT 84066 Phone: 435-709-6553 Fax: 435-236-2282 |
Mr. Samuel Smith, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1010 E 200 N, Roosevelt, UT 84066 Phone: 435-823-1769 |
News Archive
The first comprehensive, large-scale cohort study of the long-term survival of children treated for low-grade gliomas, the most common pediatric brain tumor, finds that almost 90 percent are alive 20 years later and that few die from the tumor as adults.
Cases of the Hib infection (haemophilus influenzae type b) among children and adults have risen in recent years, despite a vaccination programme which initially proved successful, say researchers in this week's BMJ.
In one of the largest studies to date to use metabolomics, the study of compounds that are created through various chemical reactions in the body, researchers have been able to identify new circulating compounds associated with the risk of developing dementia and Alzheimer's disease.
Sanofi Pasteur, the vaccines division of the sanofi-aventis Group, announced today that the U.S. Food and Drug Administration has granted licensure to expand the indication for its meningococcal conjugate vaccine, Menactra, to include a two-dose schedule for infants and children 9 months through 23 months of age.
› Verified 2 days ago